Compare iShares 7-10 Year Treasury Bond ETF (IEF) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares 7-10 Year Treasury Bond ETF vs Tilray Brands Inc — how do they compare? iShares 7-10 Year Treasury Bond ETF trades at $89.4 (market cap $41.13B), while Tilray Brands Inc trades at $3.54 (market cap $530.54M). The key difference: iShares 7-10 Year Treasury Bond ETF is far larger — about 77.5× Tilray Brands Inc's market cap, and iShares 7-10 Year Treasury Bond ETF is more actively traded (10,340,382 versus 9,099,075). Which is the better fit depends on your goals — on Pluang, investors hold iShares 7-10 Year Treasury Bond ETF for 108 Days and Tilray Brands Inc for 31 Days on average.
| IEF | TLRY | |
|---|---|---|
Market Cap | $41.13B | $530.54M |
Volume | 10,340,382 | 9,099,075 |
Sector | Fixed Income | Health |
52-Week High | $97.99 | $21.00 |
52-Week Low | $88.92 | $3.57 |
Typical Hold Time | 108 Days | 31 Days |
Enterprise Value | — | $684.46M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IEF is trading at $89.40, up 0.33% with a bearish technical signal. The ETF shows neutral oscillators but bearish moving averages, with key support at $89 and resistance at $90. Recent dividend payments of $0.31-$0.33 per share provide income, while financial ratios remain unavailable. Market sentiment reflects defensive positioning amid Treasury yield volatility.
Outlook remains cautious due to technical bearishness and bond market pressures. Opportunities include income from dividends and potential stability in defensive portfolios. Risks include continued bond market volatility and macroeconomic uncertainty affecting Treasury yields.
TLRY trades at $3.54, down 4.71% on the day and near 52-week lows, reflecting persistent bearish sentiment. The stock shows negative technical momentum with consecutive earnings misses and widening losses despite revenue growth. Recent financials reveal a net loss of $2.19B for 2025, though analyst consensus maintains a $65.01 price target with 25% buy ratings. Business developments include new product launches and leadership changes under Tilray's expanded beverage portfolio.
Outlook remains challenged by profitability concerns and high debt, but potential cannabis regulatory shifts could catalyze recovery. Investment opportunity hinges on execution improvement and market expansion, while risks include sustained cash burn and competitive pressures in the cannabis sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares 7-10 Year Treasury Bond ETF
The underlying index measures the performance of public obligations of the US Treasury that have a remaining maturity of greater than or equal to seven years and less than ten years. The fund will invest at least 80% of its assets in the component securities of the underlying index, and the fund will invest at least 90% of its assets in US Treasury securities that the advisor believes will help the fund track the underlying index.
Read more on IEF →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
